Table 1.
Case no | Gender, age ranges (years) | Primary tumor | Location | Frankel grade | Survival (days) | |
---|---|---|---|---|---|---|
Pre-operative | Postoperative | |||||
1 | F, 60–69 | Breast | T3 | B | D | 1000 |
2 | F, 70–79 | Lung | L5 | D | D | 129 |
3 | F, 60–69 | Lung | T5, T6, T11 | C | D | 325 |
4 | F, 80–89 | Bladder | L5 | C | C | 134 |
5 | F, 40–49 | Breast | L1-5 | C | C | 27 |
6 | F, 50–59 | Breast | L4 | D | D | 65 |
7 | F, 50–59 | Breast | L4 | C | D | 332 |
8 | F, 50–59 | Breast | T12, L1, L3–4 | D | D | 768 |
9 | F, 40–49 | Breast | T3–6, L3 | C | E | 971* |
10 | M, 50–59 | Liver | T4 | B | B | 198 |
11 | F, 60–69 | Lung | T3 | C | D | 134* |
12 | M, 50–59 | Lung | L3 | C | D | 572 |
13 | F, 70–79 | Lung | T6-9 | C | D | 647* |
14 | M, 50–59 | Tonsil | T5 | C | C | 635 |
15 | F, 40–49 | Breast | T8 | C | D | 49* |
16 | F, 50–59 | Breast | T11, L4, L5 | C | D | 77 |
17 | F, 30–39 | Breast | L4–5 | D | D | 280 |
18 | F, 60–69 | Breast | T11, L1, L5 | C | D | 346 |
19 | F, 60–69 | Breast | T12 | D | E | 379* |
20 | F, 70–79 | Breast | L5 | D | D | 383* |
21 | F, 50–59 | Cervix | L4 | D | D | 442* |
22 | M, 50–59 | Colon | L2 | D | D | 417 |
23 | M, 40–49 | Lung | T1–2 | B | B | 40 |
24 | M, 60–69 | Lung | T10 | D | E | 498* |
25 | F, 60–69 | Lung | L4–5 | C | D | 631* |
26 | M, 60–69 | Prostate | L4-5 | D | E | 77 |
27 | M, 70–79 | Prostate | T3, T4, T7–8 | C | C | 118 |
28 | M, 70–79 | Prostate | L2 | D | E | 344* |
29 | M, 60–69 | Prostate | T3 | C | D | 351* |
30 | F, 60–69 | Renal | L2, L4 | C | C | 36 |
*Patient was still alive at the time of the most recent contact.